Maggie Lewis

Maggie Lewis has an extensive work experience in the clinical research field. Maggie is currently the Director of Clinical Operations at Senseonics, Incorporated since February 2019. Prior to that, they worked as a Sr. Manager Clinical Affairs at Obalon Therapeutics from July 2017 to February 2019. Maggie also had a long tenure at Dexcom, starting as a Research Associate - Preclinical Studies in August 2004 and progressing through several roles including Clinical Study Manager, Sr CRA, CRA II, and CRA 1. Maggie'slast role at Dexcom was as a Clinical Study Manager from October 2014 to July 2017.

Maggie Lewis obtained a Bachelor of Science degree in Cell/Cellular and Molecular Biology from Tulane University in 2004. Maggie is currently pursuing a Master of Public Health in Epidemiology & Biostatistics at Tufts University School of Medicine, expecting to complete it in 2023.